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Tumor cell surface sialic acid levels determine a number of important properties governing cellular interactions and cell-celi co~unication. 
Towards understanding the mechanism of regulation of sialic acid levels upon cellular transformation, we have studied the regulation of expression 
of /I-galactoside a2,6_sialyltransferase in a rat tumor, the Zajdela ascitic hepatoma. We demonstrate distinct differences in the regulation of 
expression of the enzyme in the tumor cells as compared to normal liver cells. The expression of sialyltransferase is regulated both at the 
transcriptional and post-transcriptional level in a tissue-specific manner. 
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I. INTRODUCTION 
Sialic acids play an important role in a variety of 
biological processes like celllcell communication, cell- 
substrate interaction, adhesion, maintenance of serum 
glycoproteins in circulation, and protein targeting [l--6]. 
Cell surface sialic acid levels change in a regulated man- 
ner during development, differentiation, and oncogenic 
transformation [7-g]. In oncogenic transformation, cell 
surface sialic acids play an important role in determin- 
ing interactions between tumor cells and host cells, 
tumor cell immunogenicity and metastatic potential of 
the tumor cells [l&13]. 
studies that have been made on the re~lation of sia- 
lyltransferase levels. Only a few sialyltransferases have 
been purified and only one enzyme has been cloned [7]. 
The cloning of the /$galactoside a2,6&lyltransferase 
from rat liver [16] has now made it possible to examine 
the regulation of this enzyme upon cellular transforma- 
tion. 
Very little is known about the regulation of sialic acid 
levels on the cell surface consequent o cellular transfor- 
mation. Sialic acids occur at the terminal position on the 
carbohydrate groups of glycoproteins and glycolipids. 
The transfer of sialic acid to these positions occurs post- 
translationally, catalyzed by a family of glycosyltrans- 
ferases called sialyltransferases [ 14,151. More than lO- 
12 different sialyltransferases are required to synthesize 
all the known sialo-ohgosaccharide structures [7,16]. It 
has been suggested that terminal glycosylation se- 
quences present in a cell are determined by the specific- 
ity of ~ycosyltr~sferases which are present in the 
Golgi apparatus of the cell 1171. There are only a few 
In the present study, we have used a chemically in- 
duced rat tumor cell line, Zajdela ascitic hepatoma 
(ZAH), to study the regulation of expression of /I-galac- 
toside a2,6-sialyltransferase. Here we report our obser- 
vations on the regulation of mRNA levels of this sia- 
lyltransferase in ZAH cells as compared to that in nor- 
mal liver cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Cycloheximide, Dulbecco’s modified Eagle’s medium (DMEM) and 
fetal calf serum (FCS) were obtained from Sigma Chemical Co., re- 
striction enzymes from New England Biolabs and Bethesda Research 
Laboratories, and Zetaprobe membrane from Bio-Rad. [a3*P]dATP 
and [a3’P]UTP were from Jonaki, BARC, India, and [‘%]CMP-sialic 
acid was from Amersham. 
2.2. Tumor cell line 
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The ZAH cell lines were obtained from Dr. F. Zajdela, Institute de 
Radium, Orsay, France [IS]. The tumor was originally induced with 
dimethylamino~o~~ne [ 191. Tumors were maintained as ascites by 
serial transplantation of 0.5 ml of the ascitic fluid taken from a five- 
day-old tumor. Two- to three-months-old CFY rats were used 
throughout his study and the colony was propagated by sibling mat- 
ing. The results reported throughout his paper are on ZAH C, the cell 
line that was induced and maintained in female rats. The ZAH D cell 
line, induced and maintained in male rats, was also used. 
Abbreviations: ZAH, Zajdela ascitic hepatoma; DMEM, Dulbecco’s 2.3. Cell culture conditions 
modified Eagle’s medium; FCS, fetal calf serum. ZAH cells were harvested from a five-day-old tumor, washed with 
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PBS (137 mM NaCl, 2.7 mM KCI, 4.3 mM Na,HPOd7HZ0, 1.4 mM 
KH2P0,, pH 7.2). and cultured in DMEM containing 2.5% FCS at 
a density of one million cells/ml. 
Primary hepatocytes were prepared from two-month-old rats by the 
collagenase perfusion method [20] with slight modifications. Briefly, 
liver was perfused m situ with 0.05% collagenase in Ca-PBS. Free 
hepatocytes were released by gently shaking the perfused liver in the 
same buffer on a rotatory shaker. The cell viability was more than 95% 
as determined by the Trypan blue exclusion assay. The cells were 
cultured in DMEM containing 2.5% FCS. 
2.4. Assay of etqme activity 
/&Galactoside or2,6-sialyltransferase activity was estimated by the 
method of Wang et al. [21] with slight modificattons. The only differ- 
ences were that assays were carried out in 100 ~1 reaction mixtures 
using 50 nCi [‘4C]CMP-sialic acid (262 mCi/mmol) and sodium phos- 
phate buffer (0.25 mM, pH 7.0). One unit of the enzyme activity is 
defined as one pmol of [“‘Clsialic acid transferred per hour per mg of 
protein. The protein concentration was determined by Folin’s proce- 
dure as modified by Peterson [22]. 
2.5. Sialyltransferase probe preparation 
The pST1 plasmid having the sialyltransferase clone was a kind gift 
from Dr. James C. Paulson. The plasmid contams a 717 bp insert from 
near the 5’ end of the cDNA clone of rat liver /3-galactoside a2,6- 
stalyltransferase in pBR322 [16]. For DNA and RNA analysis the 
plasmid was radio-labeled by nick translation using [a-“P]dATP to a 
spectfic activity of lOa cpm/pg using a nick translation kit from Amer- 
sham according to the manufacturer’s instructions. 
2.6. Nucleic acid isolation and analysis 
DNA was isolated, restricted, and subjected to Southern blot anal- 
ysis according to standard procedures [23]. 
RNA was isolated according to the method of Chomczynski and 
Sacchi [24]. Poly(A)+ RNA was prepared by affinity purification on 
an oligo-dT-cellulose column [23]. The RNA was size fractionated on 
formaldehyde agarose gels [23], blotted onto Zetaprobe membranes 
and probed according to the manufacturer’s instructions. The final 
washing of the blots was done in 0.1 x SSPE (1 x SSPE is 180 mM 
NaCl, 10 mM NaH,PO,, 1 mM EDTA. pH 7.7) at 65°C. The blots 
were exposed to X-ray film with an intensifying screen at -70°C. 
For dot blots, aliquots containing 5, 2.5 and 1.25 pg of total RNA 
were spotted onto Zetaprobe membranes after denaturation with an 
equal volume of a solution containing 20 x SSPE and formaldehyde 
in the ratio of 60:40 at 65°C for 15 min. The blots were processed as 
described above. 
Densitometric scanning was done using a Molecular Dynamtcs 
Computing Densitometer and intensities of spots were determined by 
volume integration using Image-Quant software. 
2.7. Cvcloheximide treatment 
Forin vivo cycloheximide treatment, rats were injected wtth 50 mg 
cycloheximide per kg body weight [25]. For m vitro cultured cells, the 
cells were allowed to adapt to the culture medium for 48 h followmg 
which cycloheximide was added to a concentration of 10 ,&ml [21]. 
2.8. Nuclear run-on transcription assays 
The nuclear run-on transcription assays were carried out essentially 
as described by Greenberg [26]. Each assay mixture contained 4OOpCi 
of [a-3’P]UTP (3000 Ci/mmol). The plasmid DNA samples were lin- 
earized by using appropriate restriction enzymes. After denaturatton 
IO pug aliquots of DNA were spotted per slot. Hybridization and 
washings were done at 65°C. 
3. RESULTS 
3.1. Expression of /I-galactoside a2,6-sialyltransferase 
Determination of the sialyltransferase activity in 
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Fig. 1. (a) Northern blot showing the level and size of the sialyltrans- 
ferase transcrtpt in normal liver and ZAH cells. 10 pg of poly(A)+ 
RNA was loaded in each lane and probed with the pST1 partial cDNA 
clone (for details see section 2). (b) Densitometrtc scan of the blot 
shown in Fig. a. 
ZAH and normal liver cells showed that while normal 
liver cells contained 13.3 k 2.1 units of activity, the 
tumor cell lines had no detectable enzyme activity. 
Northern blot analysis of mRNA samples from the dif- 
ferent cell types showed that the transcript size in ZAH 
cells (Fig. la) was slightly larger than in normal liver 
cells. Furthermore, densitometric scanning showed that 
levels of the sialyltransferase mRNA from ZAH cells 
was 14.8-fold less when compared to normal liver cells 
(Fig. lb). 
3.2. Southern blot analysis 
DNA from normal liver and ZAH cells was restricted 
with EcoRI and Hind111 enzymes and subjected to 
Southern blot analysis using the sialyltransferase probe. 
No difference was observed in the blots obtained using 
DNA from liver cells or from the tumor cell lines (Fig. 
2). This observation indicates that no alteration in the 
gene, like translocation or amplification, is responsible 
for the observed difference found in the sialyltransferase 
mRNA levels in ZAH and in liver cells. 
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3.3. Nuclear run-on transcriptional analysis 
In order to examine if the sialyltransferase xpression 
is regulated at the transcriptional evel, we carried out 
nuclear run-on transcription assays on the nuclei so- 
lated from ZAH and liver cells (Fig. 3a). Densitometric 
scanning of the hybridization intensity showed that the 
transcription rate in liver cells was 3.6-fold higher than 
in ZAH cells (Fig. 3b), suggesting that the difference in 
the mRNA population in the two cell types could be a 
consequence of transcriptional regulation. The control 
hybridization with the actin plasmid showed no major 
difference in the transcription rate of the actin gene 
between the two cell types though there are large differ- 
ences in the level of mRNA (cf. Fig. la). These results 
are similar to those reported earlier [27,28]. 
3.4. Effect of cycloheximide on the levels of /3-galacto- 
side a2,iGsialyltransferase mRNA 
Dot blot experiments to determine the sialyltrans- 
ferase mRNA levels in liver cells, and in ZAH cells 
under in vivo and in vitro conditions in the presence of 
cycloheximide were carried out (Fig. 4). The results 
show dramatic differences in the levels of mRNAs. The 
in vivo experiments showed a 3-fold decrease in the 
Fig. 2. Southern blot of EcoRI- and HindIII-digested liver and ZAH 
DNA. 10 fig of digested DNA was loaded on each lane and probed 
with the pST1 sialyltransferase partial cDNA clone. 
Fig. 3. (a) Nuclear run-on transcription assay showing the level of 
transcription of sialyltransferase gene in isolated liver and ZAH nu- 
clei. (b) Densitometric scanning of run-on transcript level of sia- 
lyltransferase shown in Fig. la. 
mRNA level in liver cells as a consequence of cyclo- 
heximide treatment while there was a 16-to-17-fold in- 
crease in the level of mRNA in ZAH cells. When ZAH 
cells were isolated from the ascitic tumor, washed and 
kept in culture for 48 h, the sialyltransferase mRNA 
levels showed an increase (Fig. 4) as compared to the 
mRNA level in freshly harvested cells. When ZAH cells 
in culture were treated with cycloheximide, unlike in the 
case of in vivo experiments, there was a 3-fold decrease 
in the sialyltransferase mRNA, much the same as in the 
case of liver tissues. The liver cells maintained in culture 
as primary hepatocytes for 48 h did not show any 
change in mRNA levels as compared to mRNA levels 
in liver tissues from untreated animals (Fig. 5). 
4. DISCUSSION 
We have studied the role of alterations in cell surface 
glycosylation in cellular transformation using ZAH as 
a model system. We have used this cell line to study the 
mechanism of regulation of expression of /?-galactoside 
a2,6_sialyltransferase in comparison with that in nor- 
mal liver cells. 
149 
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Fig. 4. Dot blot showing the effect of cycloheximide on sialyltrans- 
ferase RNA in normal liver and ZAH cells in vivo and on ZAH cells 
in culture (for details see section 2). The bottom panel shows a den- 
sitometric scan of the blot. Note changes in basal RNA levels when 
ZAH cells are put in culture. CHX. cycloheximide. 
Quantitative determination of the levels of the sia- 
lyltransferase activity showed no detectable amount of 
the enzyme in the ZAH cell line. Northern blot hybrid- 
ization using mRNA from liver and the ZAH cells 
showed that down-regulation of the sialyltransferase ac- 
tivity in the tumor cells is due to a reduction at the 
mRNA level. It was also observed that the transcript 
size of ZAH cells (4.7 kb) is slightly larger than that in 
normal liver cells (4.3 kb) and corresponds to that re- 
ported for tissues other than liver, such as brain, heart, 
lung and spleen [17,29,30]. It has been proposed that 
these multiple transcripts are generated in a tissue-spe- 
cific manner from the same gene by alternative splicing 
[29,30]. This could also hold true for ZAH, since there 
is no difference in the restriction pattern of the DNA 
between ZAH and normal liver cells as determined by 
Southern blots. 
Nuclear run-on transcription assays showed a differ- 
ence in the level of transcripts generated from the nuclei 
Fig. 5. Dot blot showing that there is no change in sialyltransferase 
RNA levels when liver cells are cultured as primary hepatocytes. The 
lane on the right shows hybridization with lo,20 and 40 pg of control 
pST1 plasmid. 
of liver and ZAH cells indicating that there is a tran- 
scriptional regulation of the expression of sialyltrans- 
ferase mRNA. However, the difference in the transcrip- 
tion rate between the two cell types was only about 
3.5-fold, while a difference of about 15-fold in the level 
of mature transcript was observed in Northern blots. It 
has been suggested that when the changes in steady- 
state levels of a particular mRNA are not matched by 
a comparable change in de novo transcription as deter- 
mined by nuclear run-on assays, it gives an indication 
of post-transcriptional gene regulation [3 1,321. Our re- 
sults would indicate that post-transcriptional regulation 
of sialyltransferase mRNA is an additional factor con- 
trolling the level of expression of a2,6+.ialyltransferase. 
Treatment of ZAH and normal liver cells with the 
protein synthesis inhibitor cycloheximide altered the 
levels of sialyltransferase mRNA, suggesting that the 
maintenance of the steady-state levels of the mRNA in 
liver and ZAH cells requires continued protein synthe- 
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sis. Interestingly, upon treatment with cycloheximide 
there was an increase in the level of sialyltransferase 
mRNA in ZAH cells and a decrease in the case of liver, 
indicating that the regulation of expression of the sia- 
lyltransferase mRNA occurs in a tissue-specific manner. 
Our results are in contrast with the observations on the 
levels of this sialyltransferase in H35 hepatoma cells 
upon treatment with protein synthesis inhibitors [21]. In 
the H35 hepatoma system, protein synthesis inhibitors 
have no effect on mRNA levels. It is likely that in the 
H35 hepatoma, sialyltransferase mRNA is regulated 
through different mechanism(s). An increase in the level 
of message upon cycloheximide treatment in ZAH cells 
could results if any protein factor(s) with a short half- 
life were involved in either increasing the mRNA stabil- 
ity or negatively regulating the transcription. Direct de- 
termination of half-lives of mRNA in ZAH and liver 
cells is not possible either by the pulse-chase method 
(which is suitably only for abundantly expressed 
mRNAs [31,32]) or by using actinomycin D [33]. 
Interestingly, when ZAH cells were cultured, there 
was an increase in the level of sialyltransferase mRNA. 
Changes in the level of the sialyltransferase mRNA in 
ZAH cells upon short-term culture complements our 
observation that there are large alterations in the cell- 
surface sialic acids in ZAH cells upon culturing (manu- 
script in preparation). When ZAH cells in culture were 
subjected to cycloheximide treatment, the effect ob- 
served was similar to that observed for liver cells in the 
sense that there was a decrease in the level of transcripts. 
In contrast, in cultured primary hepatocytes there was 
no change in the level of the sialyltransferase mRNA 
level on treatment with cycloheximide as has been dem- 
onstrated earlier [21]. It is likely that the milieu in which 
the cells are present could have an influence on the 
regulation of expression of the sialyltransferase gene in 
a tissue-specific manner. This is possible since it has 
been proposed that transcripts of different lengths (4.3 
kb and 4.7 kb) are generated in a tissue-specific manner 
from different promoters [17,30], and hence regulated 
by different transcription factors. 
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